Cardinal Health stock gains 1.47 percent on fiscal growth

Cardinal Health stock (ISIN US14149Y1082) was trading at USD 224.52 on the NYSE on September 24, 2026, up 1.47 percent from the previous close. The healthcare distributor enters fiscal 2027 with adjusted EPS guidance of USD 12.40 to USD 12.60.

Fiscal revenue reaches USD 254.2 billion

Cardinal Health reported fiscal 2026 revenue of USD 254.2 billion, a 14 percent increase from fiscal 2025, according to its September 21, 2026 SEC filing published by StockTitan. GAAP operating earnings rose 15 percent to USD 2.6 billion, while operating cash flow increased 116 percent to USD 5.2 billion.

The earnings mix matters because Cardinal Health combines high-volume pharmaceutical distribution with specialty services and medical products. Its fiscal 2026 GAAP EPS reached USD 7.23, compared with USD 6.45 in fiscal 2025, a 12.1 percent increase.

Guidance points to continued growth

At the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, Cardinal Health said fiscal 2027 adjusted EPS should grow 13 percent to 15 percent, according to Investing.com. Management also outlined a USD 1 billion share repurchase plan for fiscal 2027.

The latest quarterly comparison was mixed in composition. Fourth-quarter adjusted EPS was USD 2.91 against a USD 2.42 consensus estimate, while revenue rose 5.8 percent year over year to USD 63.67 billion but came in below the USD 65.15 billion estimate, according to Zacks. That contrast puts operating execution and specialty growth ahead of headline revenue as the key measure for fiscal 2027.

Stock stays below yearly high

At USD 224.52 on September 24, 2026, Cardinal Health stock stood 13.08 percent below its 52-week high of USD 258.30 and above its 52-week low of USD 145.87. The market capitalization was USD 52,583,931,120 on the same date, giving the stock a direct valuation reference against the earnings growth profile.

More news and analyses on Cardinal Health stock